US Patent Issued to Karyopharm Therapeutics on Aug. 18 for "Crystalline form of Selinexor" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,609, issued on Aug. 18, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.).

"Crystalline form of Selinexor" was invented by Sean Howard Wiedemann (Burlington, Mass.), Bojan Dragisic (Toronto) and Stephen Edmund Gottschling (Bolton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a crystalline form of the compound represented by Structural Formula 1, and pharmaceutical compositions comprising the crystalline form of the compound represented by Structural Formula 1 described herein. The crystalline form of the compound of Structural Formula 1 and compositions comprising the crystalline form of the compound repr...